Thompson Siegel & Walmsley LLC Haemonetics Corp Transaction History

Thompson Siegel & Walmsley LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$73.85 - $86.14 $1,624 - $1,895	22 New	22 $1,000
Q3 2022 Oct 25, 2022	SELL	$63.3 - $78.66 $4.41 Million - $5.48 Million	-69,723 Reduced 28.69%	173,290 $12.8 Million
Q2 2022 Jul 22, 2022	SELL	$49.27 - $66.08 $1.78 Million - $2.39 Million	-36,129 Reduced 12.94%	243,013 $15.8 Million
Q1 2022 Apr 26, 2022	SELL	$43.77 - $63.22 $425,925 - $615,193	-9,731 Reduced 3.37%	279,142 $17.6 Million
Q4 2021 Feb 09, 2022	BUY	$49.55 - $74.59 $2.33 Million - $3.51 Million	47,110 Added 19.49%	288,873 $15.3 Million
Q3 2021 Nov 05, 2021	SELL	$57.6 - $70.59 $4.53 Million - $5.55 Million	-78,650 Reduced 24.55%	241,763 $17.1 Million
Q2 2021 Aug 09, 2021	BUY	$51.81 - $118.56 $16.6 Million - $38 Million	320,413 New	320,413 $21.4 Million

333

54M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.